Text Size

Study of Patient Satisfaction With the Cancer Clinical Trial Experience

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Joyce Neading, Summa Health System
ClinicalTrials.gov Identifier:
NCT00768976
First received: October 7, 2008
Last updated: May 22, 2012
Last verified: May 2012
History of Changes
  Purpose

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.


Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Study of Patient Satisfaction With the Cancer Clinical Trial Experience

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Summa Health System:

Primary Outcome Measures:
  • Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment. [ Time Frame: Survey will be sent to subject 3 months after study registration ] [ Designated as safety issue: No ]

Enrollment: 100
Study Start Date: October 2008
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.

Criteria

Inclusion Criteria:

  • Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
  • Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

Exclusion Criteria:

  • Participant has withdrawn consent for clinical trial participation and/or follow up.
  • Participant has a major medical illness that would prevent completion of the survey.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00768976

Sponsors and Collaborators
Summa Health System
Investigators
Principal Investigator: Joyce Neading, RHIT, CTR Summa Health System
  More Information

No publications provided

Responsible Party: Joyce Neading, Program Director, Cancer Research & Cancer Registry, Summa Health System
ClinicalTrials.gov Identifier: NCT00768976     History of Changes
Other Study ID Numbers: Clinical trial experience
Study First Received: October 7, 2008
Last Updated: May 22, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Summa Health System:
Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

ClinicalTrials.gov processed this record on May 19, 2013